Project Grant R13DC019837
- This Cooperative Agreement award of $299,430.00 from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal grant program "Research Related to Deafness and Communication Disorders" (CFDA 93.173), aims to build scientific capacity to accelerate the uptake of Dissemination and Implementation (D&I) research across NIDCD's mission areas, including hearing, balance, taste, smell, voice, speech, and language. The "Dissemination and...
- This $647,518 Project Grant award, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders (CFDA 93.173) program, supports research investigating the impact of cochlear synaptopathy on brainstem mechanisms of monaural temporal processing and binaural hearing. The study aims to understand the neural mechanisms and loci in the auditory system that produce listening difficulties, which can emerge...
- This $620,240 federal Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports an observational study examining vestibular pathophysiology and dysfunction in patients with sporadic vestibular schwannomas (SVS) and neurofibromatosis type 2-related schwannomatosis (NF2/VS). The study aims to analyze vestibular function, clinical disability, and related...
- This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $589,483 to Wayne State University to assess in vivo changes in central neuronal activation, molecular indicators of synaptic transmission, and motor function in response to vestibular nerve hypofunction generated by noise exposure. The project aims to evaluate the contributions of...
- This $450,062 federal Project Grant awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support a multi-site feasibility trial to evaluate the implementation of vestibular rehabilitation therapy for patients with dizziness and vertigo in emergency department settings. The study aims to assess the feasibility of physical therapists providing this therapy in the...
- This federal Project Grant award of $445,956, provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), is focused on establishing a molecular and physiologic biorepository of the human inner ear. The key objectives are to identify the normal physiology and molecular architecture of the human inner ear, and to determine whether findings from animal models also apply to humans,...
- This Project Grant award, valued at $157,175.00 and awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the "Research Related to Deafness and Communication Disorders" CFDA program, aims to improve the utilization of physical therapy (PT) interventions for adults with peripheral vestibular disorders (PVDs). The key objectives are to: 1) identify barriers to PT access for PVD patients, 2) develop an implementation plan to increase PT use among...
- This $115,158 Project Grant, awarded on February 1, 2025 by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the federal Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research into the neurological mechanisms underlying hearing loss. The central hypothesis is that the presentation of phosphatidylserine acts as a signal to mark inactive spiral ganglion neuron connections with outer hair cells for removal, facilitating...
- This federal Project Grant award, valued at $514,546.00 and awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports research to improve the diagnosis and treatment of benign paroxysmal positional vertigo (BPPV) and related labyrinth disorders. The project, conducted by the University of Utah, aims to achieve this goal through quantifying anatomical variance in the...
- This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), provides $767,494 to the University of Miami to develop human inner ear organoid platforms for studying genetic hearing loss and vestibular disorders. The key objectives are to: 1) establish and optimize human induced pluripotent stem cell-derived 3D inner ear organoid systems from patients with...
THE BIENNIAL VA NCRAR SCIENTIFIC CONFERENCE SERIES - PROJECT SUMMARY/ABSTRACT THE NCRAR WILL HOLD ITS NEXT THREE BIENNIAL CONFERENCES STARTING WITH "VESTIBULAR DISORDERS: FROM CAUSE TO CURE" IN FALL 2021. SUBSEQUENT CONFERENCE TOPICS ARE TENTATIVELY TITLED "POST-PANDEMIC INNOVATIONS IN CONNECTED AUDIOLOGY" AND "MULTI-SENSORY APPROACHES TO AUDITORY REHABILITATION", TO BE REFINED BASED ON DEVELOPMENTS IN THE FIELD AND PARTICIPANT FEEDBACK FROM THE PREVIOUS CONFERENCE. THESE THREE-DAY INTENSIVE CONFERENCES WILL BRING TOGETHER BASIC AND TRANSLATIONAL SCIENTISTS, CLINICIANS, PATIENTS, AND HEALTH POLICYMAKERS TO PROMOTE THE PREVENTION, DIAGNOSIS AND TREATMENT OF PATIENTS WITH HEARING AND BALANCE DISORDERS. WE HYPOTHESIZE THAT CLINICAL OUTCOMES WILL BE IMPROVED IF THEY INCORPORATE A COLLABORATIVE, INTERPROFESSIONAL CLINICAL APPROACH SHAPED BY BOTH THE PATHOPHYSIOLOGY AND THE PERSPECTIVE OF THE PATIENT. CONSISTENT WITH THE NIDCD'S 2017-2021 STRATEGIC PLAN, THESE CONFERENCES AIM TO MEET THE CRITICAL NEED FOR MULTIDISCIPLINARY APPROACHES TO DIAGNOSE AND TREAT AUDITORY AND VESTIBULAR DEFICITS APPROPRIATELY WITHIN A PATIENT-CENTERED CARE MODEL. THE OBJECTIVES OF THE 2021 CONFERENCE ARE TO ENHANCE KNOWLEDGE OF THE MECHANISMS, DIAGNOSIS, AND CLINICAL MANAGEMENT OF VESTIBULAR DYSFUNCTION. SPECIFIC TOPICS INCLUDE CELLULAR REGENERATION, AGING, HEAD TRAUMA, PSYCHOPHYSICAL TESTING, ARTIFICIAL-INTELLIGENCE GUIDED DIAGNOSIS, VIRTUAL REALITY-BASED REHABILITATION, AND VESTIBULAR IMPLANTATION. PANEL DISCUSSIONS WITH PATIENTS AND EXPERTS AND CURATED MATCHING OF MENTORS WITH STUDENTS PROVIDE VALUABLE COMMUNICATION AND NETWORKING OPPORTUNITIES. A NOVEL ASPECT OF THE CONFERENCE SERIES IS THE INCLUSION OF STAKEHOLDERS, SUCH AS PATIENTS AND POLICYMAKERS, WITHIN THE CLINICAL TEACHING SESSIONS. AN INNOVATIVE ASPECT IS TO OPTIMIZE THE RELEVANCE OF THE CASE-STUDY FOCUSED PROBLEM-BASED LEARNING SESSIONS BY POLLING ATTENDEES REGARDING THEIR CHALLENGES IN CLINICAL RESEARCH AND PATIENT CARE. A CLOSING DISCUSSION WITH THE PRESENTERS AND AUDIENCE WILL RECAP RECOMMENDATIONS FOR FUTURE RESEARCH AND DEVELOPMENTS IN CLINICAL CARE. THE CONFERENCE WILL BE LIMITED TO 200 ATTENDEES TO CREATE AN INTIMATE ENVIRONMENT ENHANCING OPEN COMMUNICATION. TEN SCHOLARSHIPS PROVIDED TO STUDENTS AND 5 TO PRACTICING CLINICIANS WILL ATTRACT PARTICIPANTS FROM OUTSIDE THE SCIENTIFIC COMMUNITY, WITH AT LEAST 8 SCHOLARSHIPS AWARDED TO APPLICANTS WHO ARE WOMEN, PART OF A RACIAL/ETHNIC MINORITY GROUP, OR HAVE A DISABILITY. THE CONFERENCE WILL BE PUBLICIZED THROUGH SOCIAL MEDIA, EMAIL AND OTHER PROFESSIONAL MEETINGS. ANNOUNCEMENTS WILL BE POSTED ON THE NCRAR WEBSITE, PROFESSIONAL ORGANIZATION WEBSITES, AND PUBLISHED IN SPECIALTY JOURNALS. CONFERENCE CONTENT WILL BE DISSEMINATED TO NON- ATTENDEES VIA A SPECIAL ISSUE OF THE AMERICAN JOURNAL OF AUDIOLOGY, AND THE CONFERENCE PRESENTATIONS WILL BE AVAILABLE AT A REDUCED PRICE ON THE NCRAR WEBSITE (WITH PRESENTER PERMISSIONS).
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $36.7k | 9/23/25 | ||
| Not listed | $100 | 8/16/24 | ||
| Not listed | $39.7k | 8/15/23 | ||
| Not listed | $100 | 8/11/22 | ||
| Not listed | $100 | 8/11/22 |